wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38128723-0C54404A-ADCC-4DBD-A4FF-45980BB0D0D5
Q38128723-0C54404A-ADCC-4DBD-A4FF-45980BB0D0D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38128723-0C54404A-ADCC-4DBD-A4FF-45980BB0D0D5
The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients.
P2860
Q38128723-0C54404A-ADCC-4DBD-A4FF-45980BB0D0D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38128723-0C54404A-ADCC-4DBD-A4FF-45980BB0D0D5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
76e671189a8103494b0572666a849a6d6439a6bc
P2860
Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance.